Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients

Journal of NeuroVirology

Volumn 2, Issue 5, 1996, Pages 323-329

  Fox, Robert J ^a   Levin, Michael C ^a   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cytokine; HTLV I associated myelopathy tropical spastic paraparesis; In situ hybridization; Tumor necrosis factor alpha

Indexed keywords

CD45 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOPSY; CASE REPORT; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MALE; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD; SPINAL CORD DISEASE;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029836989     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289609146896     Document Type: Article

References (31)

1. Brosnan CF, Selmaj K, Raine CS (1988). Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 18: 87-94.
2. Cannella B, Raine CS (1995). The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37: 424-435.
3. Hoffman PM, Dhib-Jalbut S, Mikovits JA, Robbins DS, Wolf AL, Bergey GK, Lohrey NC, Weislow OS, Ruscetti FW (1992). Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc Natl Acad Sci USA 89: 11784-11788.
4. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989). Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170: 607-612.
5. Hollsberg P, Hafler DA (1993). Pathogencsis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 328: 1173-1182.
6. Ijichi S, Eiraku N, Osame M, Izumo S, Kubota R, Maruyama I, Matsumoto M, Niimura T, Sonoda S (1989). Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP). J Neuroimmunol 25: 251-254.
7. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990). Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-248
8. Kobayashi N, Hamamoto Y, Yamamato N (1990). Production of tumor necrosis factors by human T-cell lines infected by HTLV-1 may cause their high susceptibility to human immunodeficiency virus infection. Med Microbiol Immunol 179: 115-122.
9. Kuroda Y, Matsui M, Takashima H, Kurohara K (1993). Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J Neuroimmunol 45: 133-136.
10. Kuroda Y, Matsui M (1993). Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol 42: 223-226.
11. Lahdevirta J, Maury CP, Teppo A, Repo H (1988). Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85: 289-291.
12. Lal RB, Rudolph DL (1991). Constitutive production of interleukin-6 and tumor necrosis factor-alpha from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II. Blood 78: 571-574.
13. Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M, Jacobson S (1995). Detection of Human T-Lymphotropic Virus Type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 47: 167-175.
14. Levin MC, Fox RJ, Lehky T, Walter M, Fox CH, Flerlage N, Bamford R, Jacobson S (1996). Polymerase chain reaction/in situ hybridization detection of HTLV-I-tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-I associated neurologic disease. J Virol 70: in press.
15. Lieberman AP, Pitha PM, Shin HS, Shin ML (1989). Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotrophic virus. Proc Natl Acad Sci USA 86: 6348-6352.
16. Mintz M, Rapaport R, Oleske JM, Connor EM, Koenigsberger MR, Denny T, Epstein LG (1989). Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 143: 771-774.
17. Moore GRW, Traugott U, Scheinberg LC, Raine CS (1989). Tropical Spastic Paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol 26: 523-530.
18. Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K (1993). Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. N Neuroimmunol 42: 127-130.
19. Nishimoto N, Yoshizaki K, Eiraku N, Machigashira K, Tagoh H, Ogata A, Kuritani T, Osame M, Kishimoto T (1990). Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/ tropical spastic paraparesis. J Neurol Sci 97: 183-193.
20. Ohbo K, Sugamura K, Sekizawa T, Kogure K (1991). Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy. Neurology 41: 594-595.
21. Selmaj K, Raine CS, Cannella B, Brosnan CF (1991). Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949-954.
22. Selmaj KW, Raine CS (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339-346.
23. Tendler CL, Greenberg SJ, Burton JD, Danielpour D, Kim SJ, Blattner WA, Manns A, Waldmann TA (1991). Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 46: 302-311.
24. Tschachler E, Robert-Guroff M, Gallo RC, Reitz MS Jr (1989). Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. Blood 73: 194-201.
25. Tyor WR, Glass JD, Baumrind N, McArthur JC, Griffin JW, Becker PS, Griffin DE (1993). Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 43: 1002-1009.
26. Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M (1993). Immunocytochemical analysis of the cellular infiltrates in the spinal cord lesions in HTLV-I associated myelopathy. J Neuropathol and Exp Neurol 52: 424-430.
27. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M (1994). Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropath Exp Neurol 53: 72-77.
28. Waage A, Halstensen A, Shalaby R, Brandtaeg P, Espevik T (1989). Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 170: 1859-1867.
29. Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, Van Arsdell JN, Yamamoto R, Mark DF (1985). Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228: 149-154.
30. Watanabe H, Nakamura T, Nagasato K, Shirabe S, Ohishi K, Ichinose K, Nishiura Y, Chiyoda S, Tsujihata M, Nagataki S (1995). Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell leukemia virus type I-associated myelopathy. Arch Neurol 52: 276-280.
31. Wu E, Dickson DW, Jacobson S, Raine CS (1993). Neuroaxonal dystrophy in HTLV-I-associated myelopathy/tropical spastic paraparesis: neuro pathologic and neuroimmunologic correlations. Acta Neuropathol 86: 224-235.